Abstract: An axial flux switched reluctance motor and/or generator, and controls are provided. It includes a stator, which includes a front surface and a rear surface, and sidewalls that extend from the front surface to the rear surface. The stator includes salient stator poles positioned on the front surface. Each one of the salient stator poles including: a bobbin protruding out from the front surface in a direction along an axis of the bobbin that is perpendicular to the front surface; the bobbin comprising a bobbin front surface that is substantially parallel to the front surface of the stator; and a coil of electrically insulated wire wound around the bobbin. A rotor includes a front rotor surface and an opposite facing rear rotor surface; and further includes a plurality of rotor poles. The rotor is affixed to a shaft and rotates about an axis of rotation that is aligned with the shaft.

Abstract: In some examples, a system receives measurement data from measurements of first three-dimensional (3D) parts formed on a build bed of an additive manufacturing machine with different contone levels of a liquid agent, and determines, based on the measurement data, geometrical deviations of the first 3D parts from a baseline geometrical property. The system generates, based on the determined geometrical deviations, a model that correlates contone levels of the liquid agent to corresponding geometrical deviations, the model for use in an adjustment of the liquid agent based on a contone level adjustment to compensate for a geometrical deviation when building second 3D parts with the additive manufacturing machine or another additive manufacturing machine.

Abstract: A state machine includes a stator assembly arranged to generate a rotating electromagnetic field in response to a control signal and a rotor assembly, positioned adjacent to the stator assembly, arranged to rotate in response to the rotating electromagnetic field. A sensor is arranged to detect an angular position of the rotor assembly and output sensor data based on the angular position of the rotor assembly. A controller is arranged to receive the sensor data and adjust the control signal based on the angular position of the rotor assembly to adjust a torque of associated with the rotor assembly when the state machine functions as a motor or to adjust a power output from the stator assembly when the state machine functions as a generator.

Abstract: Targeting metastasis stem cells through a fatty acid receptor. The invention provides the use of blockers or inhibitors of CD36 activity or expression for the treatment of oral squamous cell cancer (OSCC), particularly for the treatment of generated metastases and for diminish is generation from primary tumours. Apart from shRNAs, anti-CD36 antibodies are provided as blockers or inhibitors, especially those that block the binding of CD36 to oxidized LDL and fatty acids and their incorporation into cells, because the promotion of their transport is indicated as the mechanism by which CD36 promote metastases dissemination and growth. Also provided is a method for identifying candidates to anticancer agents, particularly for OSCC metastasis, among those that promote in CD36+ cells, in vivo or in vitro, effects associated to CD36 depletion or blocking such as decrease of growth accumulation of lipid droplets and decrease of size in the case of metastases.

Abstract: Targeting metastasis stem cells through a fatty acid receptor. The disclosure provides the use of blockers or inhibitors of CD36 activity or expression for the treatment of oral squamous cell cancer (OSCC), particularly for the treatment of generated metastases and for diminish is generation from primary tumours. Apart from shRNAs, anti-CD36 antibodies are provided as blockers or inhibitors, especially those that block the binding of CD36 to oxidized LDL and fatty acids and their incorporation into cells, because the promotion of their transport is indicated as the mechanism by which CD36 promote metastases dissemination and growth. Also provided is a method for identifying candidates to anticancer agents, particularly for OSCC metastasis, among those that promote in CD36+ cells, in vivo or in vitro, effects associated to CD36 depletion or blocking such as decrease of growth accumulation of lipid droplets and decrease of size in the case of metastases.

Abstract: Metastasis stem cells are targeted through a fatty acid receptor. Blockers or inhibitors of CD36 activity or expression are for the treatment of oral squamous cell cancer (OSCC), particularly for the treatment of generated metastases and for diminishing generation from primary tumors. Apart from shRNAs, anti-CD36 antibodies are provided as blockers or inhibitors, especially those that block the binding of CD36 to oxidized LDL and fatty acids and their incorporation into cells, because the promotion of their transport is indicated as the mechanism by which CD36 promote metastases dissemination and growth. A method identifies candidates to anticancer agents, particularly for OSCC metastasis, among those that promote in CD36+ cells, in vivo or in vitro, effects associated to CD36 depletion or blocking such as decrease of growth accumulation of lipid droplets and decrease of size in the case of metastases.